Kemoteraapias kasutatavate ravimite ja immuunmodulaatorite ostmine
Contracts total
3 612 967 €
Bids
4
Type
Supplies
Published
23.09.2024
Tender description
Hanke eesmärk on sõlmida raamleping kemoteraapias kasutatavate ravimite ja immuunmodulaatorite ostmiseks Lisas 1 toodud nimetuste ja kirjelduste alusel. Käesolev hange on jaotatud 27-ks osaks. Pakkumuse võib esitada kas ühele või mitmele osale.
Awarded contracts
30.12.2024| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| L01AA07 - Trofosamid | TAMRO EESTI OÜ | 13 325 € | 2 | 02.12.2024 |
| L01AX03 - Temozolomid | MAGNUM MEDICAL OÜ | 1807 € | 1 | 06.12.2024 |
| L01AX03 - Temozolomid | TAMRO EESTI OÜ | 9183 € | 2 | 02.12.2024 |
| L01AX03 - Temozolomid | TAMRO EESTI OÜ | 7788 € | 2 | 02.12.2024 |
| L01BC06 - Capetsitabin | MAGNUM MEDICAL OÜ | 14 742 € | 2 | 06.12.2024 |
| L01BC06 - Capetsitabin | MAGNUM MEDICAL OÜ | 97 344 € | 2 | 06.12.2024 |
| L01BC07 - Azactidinum | Apteegikaubanduse Hulgimüük OÜ | 91 120 € | 2 | 28.11.2024 |
| L01DA01 - Dactinomycin | osaühing KALVERTON | 3640 € | 4 | 10.12.2024 |
| L01CD02 - Docetaxel | TAMRO EESTI OÜ | 53 138 € | 2 | 02.12.2024 |
| L01DB03 - Epirubicin | TAMRO EESTI OÜ | 86 502 € | 1 | 02.12.2024 |
| L01FE02 - Panitumumab | MAGNUM MEDICAL OÜ | 325 229 € | 1 | 06.12.2024 |
| L01FF04 - Avelumab | TAMRO EESTI OÜ | 102 310 € | 2 | 02.12.2024 |
| L01FD03 - Trastuzumab emtasin | Roche Eesti Osaühing | 739 452 € | 1 | 28.11.2024 |
| L01FD03 - Trastuzumab emtasin | Roche Eesti Osaühing | 739 456 € | 1 | 28.11.2024 |
| L01FX02 - Gemtuzumabosogamitsiin | MAGNUM MEDICAL OÜ | 351 415 € | 1 | 06.12.2024 |
| L01XX27 Arsenii trioxid | TAMRO EESTI OÜ | 93 600 € | 1 | 02.12.2024 |
| L01XG01 - Bortezomib | Apteegikaubanduse Hulgimüük OÜ | 43 862 € | 3 | 28.11.2024 |
| L01XX41 - Eribuliin | TAMRO EESTI OÜ | 339 446 € | 1 | 02.12.2024 |
| L01XG02 - Carfilzomib | MAGNUM MEDICAL OÜ | 321 443 € | 1 | 06.12.2024 |
| L03AA02 - Filgrastim 300mcg/0,5ml | MAGNUM MEDICAL OÜ | 97 617 € | 2 | 06.12.2024 |
| L03AA13 - Pegfilgrastim 10mg/ml-0,6ml | MAGNUM MEDICAL OÜ | 80 548 € | 2 | 06.12.2024 |
Tender lots
27| Lot | Estimated value | Deadline |
|---|---|---|
| L01AA03 - Melphalan | 28.10.2024 | |
| L01AA07 - Trofosamid | 28.10.2024 | |
| L01AX03 - Temozolomid | 28.10.2024 | |
| L01AX03 - Temozolomid | 28.10.2024 | |
| L01AX03 - Temozolomid | 28.10.2024 | |
| L01BA03 - Methotrexate | 28.10.2024 | |
| L01BB05 - Fludarabin | 28.10.2024 | |
| L01BC06 - Capetsitabin | 28.10.2024 | |
| L01BC06 - Capetsitabin | 28.10.2024 | |
| L01BC07 - Azactidinum | 28.10.2024 | |
| L01CA01 - Vinblastin | 28.10.2024 | |
| L01DA01 - Dactinomycin | 28.10.2024 | |
| L01CD02 - Docetaxel | 28.10.2024 | |
| L01DB03 - Epirubicin | 28.10.2024 | |
| L01DB06 - Idarubicin | 28.10.2024 | |
| L01FE02 - Panitumumab | 28.10.2024 | |
| L01FF04 - Avelumab | 28.10.2024 | |
| L01FD03 - Trastuzumab emtasin | 28.10.2024 | |
| L01FD03 - Trastuzumab emtasin | 28.10.2024 | |
| L01FX02 - Gemtuzumabosogamitsiin | 28.10.2024 | |
| L01XX27 Arsenii trioxid | 28.10.2024 | |
| L01XX27 - Arsenii trioxid | 28.10.2024 | |
| L01XG01 - Bortezomib | 28.10.2024 | |
| L01XX41 - Eribuliin | 28.10.2024 | |
| L01XG02 - Carfilzomib | 28.10.2024 | |
| L03AA02 - Filgrastim 300mcg/0,5ml | 28.10.2024 | |
| L03AA13 - Pegfilgrastim 10mg/ml-0,6ml | 28.10.2024 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 2 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 2 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 3 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 5 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 9 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 9 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.